Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Down – What’s Next?

Shares of Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY) gapped down prior to trading on Tuesday . The stock had previously closed at $19.05, but opened at $18.26. Daiichi Sankyo shares last traded at $18.31, with a volume of 17,951 shares trading hands.

Daiichi Sankyo Stock Performance

The business has a 50 day moving average price of $18.41 and a 200-day moving average price of $21.14. The firm has a market cap of $33.80 billion, a price-to-earnings ratio of 16.37, a price-to-earnings-growth ratio of 0.93 and a beta of -0.04. The company has a quick ratio of 1.85, a current ratio of 2.69 and a debt-to-equity ratio of 0.18.

Daiichi Sankyo (OTCMKTS:DSNKY) last released its quarterly earnings results on Thursday, January 29th. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.05. The business had revenue of $3.65 billion during the quarter, compared to analyst estimates of $3.88 billion. Daiichi Sankyo had a net margin of 14.83% and a return on equity of 18.64%. As a group, research analysts expect that Daiichi Sankyo Co., Ltd. – Sponsored ADR will post 1.04 EPS for the current fiscal year.

About Daiichi Sankyo

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.